Stockreport

Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior [Yahoo! Finance]

UCB SA UNSP/ADR  (UCBJY) 
NASDAQ:AMEX Investor Relations: ucb.com/investors
PDF No new safety signals were reported, reinforcing the consistent safety profile seen in previous studies Long-term data on the treatment of seizures in children and ad [Read more]